Fahmi Fathurrahman

Experience

• 

  Citi

  Apr 2015 - Jul 2016

  Project Management Officer

  1. Supported the implementation of chip-enabled debit cards in Indonesia, ensuring regulatory compliance and smooth transition from magnetic stripe technology.2. Managed end-to-end project coordination, including planning, execution, and monitoring, to deliver milestones on time and within scope.3. Collaborated with cross-functional teams and external stakeholders to identify risks, resolve issues, and align project goals.

• 

  Novartis

  Dec 2018 - Dec 2022

  1. Handled Entresto (Sacubitril/Valsartan), Novartis’ global blockbuster and top company priority, as one of the youngest product managers entrusted with a high-profile brand.2. Doubled sales during tenure by securing inclusion in Indonesia’s National Health Insurance (JKN), making the drug more accessible nationwide.3. Led brand awareness initiatives targeting government hospitals, ensuring wide adoption and positioning Entresto as a standard of care in heart failure treatment. 1. Supported the launch of Secukinumab (Fraizeron) for new rheumatology indications, one of Indonesia’s earliest biologic therapies.2. Partnered with senior product managers to design and execute launch strategies that quickly positioned Fraizeron as the market leader in its category.3. Conducted market analysis and cross-functional coordination to ensure successful adoption and strong HCP engagement. 1. Built early expertise in KOL engagement, event management, and project execution, learning to translate insights into actionable strategies.2. Supported the Product Manager in handling Cataflam, the market leader in pain management, gaining experience in managing a top portfolio brand.

  • Junior Product Manager

    Dec 2020 - Dec 2022

  • Product Executive

    Dec 2019 - Dec 2020

  • Management Trainee in Derma, Rheumato, Pain, and Neuroscience

    Dec 2018 - Dec 2019
• 

  Haleon

  Dec 2022 - now

  1. Launched Sensodyne Cavity & Sensitivity in Indonesia (2025), aligning the brand with the nation’s biggest oral health concern (cavities). Officially introduced at the Annual Indonesia Dentist Association Conference in Surabaya. Within months, the variant became a core portfolio pillar, already exceeding year-to-date targets.2. Strengthened dentist engagement nationwide through collaborations with 35 local dentist associations, delivering CME programs via seminars, webinars, and community service, reaching 15,000+ dentists in 2025.3. Expanded digital outreach to pharmacists through SwipeRx, initiating webinars, articles, and interactive quizzes, reaching 5,000+ pharmacists across Indonesia.4. Support Polident “Balikin Senyum” (Bring Back Smiles) campaign (2024), providing free dentures and oral health education to underserved communities. The initiative reinforced Polident’s social impact and drove highest sales growth among Haleon brands in 2024.5. Recognition: Candidate, Best Manager – Haleon Indonesia (2024) | Winner, Most Innovative Brand Campaign – Oral Health Care (2024) Show less 1. Pioneered Panadol “Klinik Cekatan” (Quick Response Clinic) campaign, improving healthcare access in underserved areas by equipping field teams with mobile toolkits to connect patients in remote communities with GPs in major cities. The program benefited 20,000+ participants.2. Revolutionized data management by creating a centralized Excel-based system for sales, call activity, and sample delivery tracking. This shift from manual, team-leader–dependent reporting to a daily automated dashboard dramatically improved efficiency, enabling medical reps to operate more effectively and managers to make quicker, data-driven decisions.3. Strengthened Panadol’s position as a trusted brand in community health through impactful medical education initiatives and HCP partnerships.4. Recognition: Winner, Best Manager – Haleon Indonesia (2023) | Winner, Most Innovative Brand Campaign – OTC (2023) Show less

  • Medical Marketing Manager (Oral Health Care Category)

    Oct 2024 - now

  • Medical Marketing Manager OTC Category

    Dec 2022 - Sept 2024